Interfacing Chemistry with Patents

Published: 6-Jun-2013

12 - 13 November 2013

Training course

London, UK


This course is an introduction to how the patent system works and the nature and scope of the rights a patent gives, with an emphasis on chemical inventions. It covers patentability, patent procedures, infringement, the commercial exploitation of patents, the interpretation of patent literature and the role of the inventor.

Organiser: Scientific Update

Trending Articles

  1. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  2. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  3. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  4. Vision Pharma <b>28 February - 1 March 2012</b><br> <i>Exhibition</i><br> Messe Karlsruhe, Germany
  5. Advanced Characterisation Techniques for Solid Pharmaceutical Dosage Forms <b>5 July 2013</b><br> <i>PSSRC Open Day</i><br> University of Lille, France

You may also like

Digital

Pharma cybersecurity challenges: a holistic prescription

The pharmaceutical sector remains a prime target for cyberattacks. As an industry built on innovation, with extensive investments in research and development (R&D), intellectual property (IP) and patient information, it bridges the divide between business and healthcare, becoming a hotspot in the health data threat landscape
Regulatory

Pharmaseal reaches milestone in crowdfunding campaign

The company was first founded in 2016
Patient Experience

Ilya Pharma awarded engineered lactic acid bacterial strain patent

The patent covers the use of engineered lactic acid bacterial strains for all human and animal wounds, not just skin
Pharmaceutical

A card in the competition for COVID-19 drug supply

The patent system has come under pressure both politically and, more recently, as pharma companies scale-up their operations to make large amounts of drugs available to treat COVID-19, reports Paul England, Senior Professional Support Lawyer at Taylor Wessing
Ingredients

Sigrid Therapeutics obtains US patent for silica-based biomaterial SiPore15 for the treatment and prevention of obesity

Mesoporous silica particles (MSP) are a type of ingestible synthetic amorphous silica particles that can be produced with a large surface area and a range of pore sizes
Ingredients

VistaGen and Nuformix agree to develop cocrystalline forms of AV-101

The drug for treatment of multiple CNS conditions will be reformed into a novel patentable form to potentially improve delivery and give more intellectual property protection
Digital

Documentation complexity at crisis point?

Do we focus too much on the paperwork, to the detriment of product and patients? Has documentation become so complex it’s become a dangerous distraction and your biggest risk? by Martin Lush
Subscribe now